Nu Skin Enterprises, Inc. Class A (NUS)

Nu Skin Enterprises' stock price has experienced volatility and declines in the past six months. In Q1 2026, Nu Skin reported earnings that significantly missed analyst expectations, leading to a drop in the stock price. Revenue and field-force contraction were observed, attributed to macroeconomic pressures and disruptions from the company's sales-model transformation. Net income in Q1 2026 dropped significantly, impacted by charges related to winding down the BeautyBio business. For Q2 2026, Nu Skin expects revenue between $330 million and $360 million and EPS between $0.15 and $0.25. The company sold its Mavely platform in 2025 and is investing in its Prysm iO intelligent wellness platform. Nu Skin ended Q1 2026 with $200.4 million in cash and current investments and $225 million of total debt.

Nu Skin Enterprises has explicitly stated that the first quarter of the year is typically its lowest quarter due to the seasonality of its business. The company's growth has also been described as "lumpy," historically driven by periodic launches of new devices, indicating that demand can fluctuate significantly based on product innovation and release cycles.

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. The company operates within the consumer defensive sector, focusing on household and personal products, and the personal products and food products industries. Nu Skin's mission is to empower individuals globally through rewarding business opportunities, innovative products, and an enriching culture, with a vision to become a leading integrated beauty and wellness company powered by its affiliate opportunity platform. Under its primary brands, Nu Skin and Pharmanex, the company offers a comprehensive line of beauty and wellness solutions, including personal care/beauty products, nutritional supplements, and weight management products.

Nu Skin Enterprises has a significant global presence, operating in approximately 50 to 54 markets worldwide. Its operational structure is segmented across several key regions, including the Americas, Mainland China, South Korea, Southeast Asia/Pacific, Japan, Hong Kong/Taiwan, and Europe & Africa. The company began its international expansion in Canada in 1990, followed by Asia in 1991. Nu Skin is also preparing for expansion into India, with a market pre-opening in Q4 2025 and a formal launch in mid-2026.

Nu Skin has been accredited by the Better Business Bureau (BBB) since 1986 and holds an A+ rating. The company is also a member of the Direct Selling Association (DSA) and the World Federation of Direct Selling Associations (WFDSA). However, Nu Skin's business model, a multi-level marketing (MLM) structure, has historically faced scrutiny. More recently, the company experienced a decline in its customer base in Q1 2025, which could impact brand perception. The winding down of the BeautyBio business in Q1 2026 also resulted in charges, which could reflect on strategic decisions and brand portfolio management.

Nu Skin Enterprises' ownership is a mix of institutional investors, individual insiders, and retail investors. Institutional investors are the dominant force, collectively holding a significant majority of the company's stock. Major institutional shareholders include Vanguard Group Inc., BlackRock, Inc., and Charles Schwab Investment Management Inc. Insiders, including the company's founders and executives, maintain a notable presence in Nu Skin Enterprises stock ownership. Key individual shareholders include Blake Roney, Sandra Tillotson, and Steven Lund. Retail investors account for roughly 21.67% to 23% of the outstanding shares.